National Vision Holdings EYE Q1 2026 Earnings EPS Surprise Lifts Stock After Revenue Shortfall LOAN Q1 2026 Earnings EPS Slightly Misses Estimates Stock Declines NGNE Q1 2026 Earnings EPS Falls Short of Consensus as PreRevenue Biotech Maintains RD Focus ISSC Q1 2026 Earnings Strong EPS Beat Amid Limited Revenue Disclosure Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances GNK Q1 2026 Earnings Significant EPS Beat Amid Challenging Market Conditions